Cargando…
The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000918/ https://www.ncbi.nlm.nih.gov/pubmed/35418757 http://dx.doi.org/10.2147/OTT.S369352 |
Ejemplares similares
-
The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway
por: Jia, Linwei, et al.
Publicado: (2018) -
The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT/β-catenin pathway [Retraction]
Publicado: (2019) -
LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Publicado: (2023) -
Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2021) -
Retracted: Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)